chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a currently 67-year-old male patient. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On or about 09-OCT-2013, at the age of approximately 67-year-old, the patient was administered with zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions (lot#, expiration date, dosage and route of administration not specified). On an unknown date, the patient was treated by a healthcare provider for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: shingles. At the time of the report, the outcome of shingles was unknown. The reporter considered that shingles was related to Zoster Vaccine Live (ZOSTAVAX).   Additional information has been requested.
I had feelings of vertigo and partial hearing loss in my left ear. My balance was off when walking and I felt like I was going to pass out or fall. The vertigo was relieved when I sat or laid down. This symptoms left after a day but the vertigo lasted for 2 weeks or longer with both injections. It has been over a month since I had both injections and both adverse reactions have now disappeared.
After a few hours, developed a low grade headache and some soreness at the injection site.  About two hours later I started getting extremely cold, despite the temperature in the mid-high 70s. I covered up under blankets. I began feeling very tired and a general sick feeling. After about an hour and a half of progressively worse chills and cold sweat, I began to get very very hot and removed all blankets and eventually clothes. I took my temperature, which was at 102 f. At this point I drank some water and Gatorade and waited for it to pass. I also noticed that my Apple Watch heart rate detection was saying my heart rate was in the high 90s to low 100s despite me just laying in bed. This was alarming because my typical resting heart rate is in the low 60s. About two hours later I felt well enough to at least brush my teeth, but upon standing up was greeted with an extreme feeling of weakness and dizziness and it was hard to keep myself up right. I eventually was able to fall asleep, and upon waking up, felt better, but still not great. My heart rate was more normal at this point, I no longer had chills or a fever, but still had a headache and soreness across my body, worst at the injection site.
pt had vax 25OCT94 on 26OCT94 mom reported 4" red area to lt arm;
PATIENT SUFFERED AN ISCHEMIC OCCIPITAL LOBE STROKE, CONFIRMED BY CT SCAN, ON 4/2/2021. PATIENT WAS TRANSFERRED TO AND ADDMITTED TO HOSPITAL. PATIENT WAS NOT ADMITTED TO THE ICU PER HIS WIFE. PATIENT WAS RECENTLY TRANSFERED TO REHAB WHERE IS HE IS CURRENTLY AS OF 4/13/2021. PATIENT LOST VISION IN LEFT EYE AS WELL AS FUNCTION IN HIS LEFT ARM PER THE PATIENTS WIFE. PATIENT IS REGAINING SIGHT AND STRENGTH IN BOTH HIS LEFT EYE AND ARM BUT PROGRESS IS SLOW, PER HIS WIFE.
pt developed rash on the left inner leg post 1st covid shot immediately, some itching. Rash has not resolved as of right now week 5 post 1st covid. shot.  pt developed rash all over her body post 2nd covid shot. Itchy.
C/o headache dizzy for a couple of weeks. Onset day after receiving vaccines 3/5/10. Tx with 200mg Motrin every 6-8 hrs. Taken to Doctor 3/11/10 told sinus problems and prescribed Sildec Pe- DM calling today because still having headaches. Advised to notify Doctor.
pt admitted to hosp with worsening SOB; O2 supplementation; positive for COVID in ED; CXR shows bilateral infiltrates; pt's condition worsened requiring more O2; given ABX and dexamethasone; pt continued to deteriorate; transitioned to comfort measures per pt's request; he passed away in the hospital
Information has been received from a 67 year old female consumer with no medical history and no allergies who on 10-NOV-2006, at a store, was vaccinated in the upper arm with a 0.5 ml dose of Pneumovax 23.  Concomitant therapy included unspecified blood pressure medication.  On 10-NOV-2006, twelve hours after receiving the vaccine, the consumer experienced pain from the injection in her upper arm all the way up to her neck.  She said she developed 4 "raised welts in the general area of the injection" and an area of redness with fluid in it around her collar bone.  Unspecified medical attention was sought.  No lab tests were performed.  On 14-NOV-2006 the patient recovered.  No product quality complaint was involved.  No further information is expected.
no symptoms reported; patients received improperly stored vaccine; This spontaneous report was received from nurse practitioner refers to unspecified number of patients of unknown demographics.   On an unknown date in 2019 (reported as unspecified dates beginning sometime after 22-MAY-2019), unspecified number of patients were vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot# R024144, expiration date:30-AUG-2020) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot# R018778, expiration date:18-DEC-2019) (strength, dose, frequency were not reported) for prophylaxis. Concomitant therapies included sterile diluent (STERILE DILUENT) which was used to reconstitute the vaccines and was stored properly.  It was reported that the patients received improperly stored vaccines (product storage error). The temperature excursion for the vaccines was reported as 6.4 degree Fahrenheit for 60 minute, 7.7 degree Fahrenheit for 60 minutes and 7.0 degree Fahrenheit for 60 minutes. There were no previous temperature excursions. Digital data logger was involved. No product quality complaint was involved. The outcome of product storage error was unknown.  Lot No. R024144 has been verified to be a valid lot number for [varicella virus vaccine live], expiration date reported as 30-AUG-2020, but upon internal validation established as 23-AUG-2020.  Lot No. R018778 has been verified to be a valid lot number for [measles, mumps, rubella and varicella], expiration date reported as 18-DEC-2019, but upon internal validation established as 29-DEC-2019.  This case was considered as non-valid due to lack of patient identifiers.
Patient requested a Pfizer bivalent booster and was given a Pfizer monovalent booster. Patient has a history of receiving Pfizer monovalent COVID vaccine and no history of receiving a bivalent vaccine.  The patient was notified in the morning of 12/09/22 as soon as the pharmacy became aware. Per the CDC guidelines, a repeat dose is not recommended and a bivalent booster can be administered if desired 2 months following this current dose. The patient was encouraged to contact the pharmacy with any questions or concerns.
#4 ANTHRAX VACCINE GIVEN R DELTOID THUR 10/7/04-REDNESS/CELLULITIS STARTED NEXT DAY. TODAY IN ED 7 IN BY 5 IN LARGE AREA OF CELLULITIS.
10-9-07 SHOT ADMINISTERED; 10-10-07 Nausea - Shoulder Blade pain - muscle spasms; 10-11-07 Pain spread to back then down arms; 10-12-07 Pain and spasms Head and Temple Continual Burning feeling. ER visit MD stated Flu shot problems; 10-15-07 WENT TO OWN MD. Put on Valium Muscle Relaxant and Pain med; 110-31-07 Doing well now
After the vaccine, I had a sore spot on my arm and that was it. And then around the same time as I started experiencing severe dizziness with moments of vertigo (something might have been happening before my second dose in February and then it was progressing as far as kicking in, in March ) and these progressed over the next 6 months - each month the symptoms got worse and worse. I was falling. I was having severe episodes when I thought it might have been a seizure - thrown to the floor.  I went to ER in July - .. My primary care physician - Dr. He  sent me to endocrinologist and then I saw two cardiologists and then a neurologist and then an audiologist and ear, nose and throat specialist. The ENT Oto something  (specializes in ear/nerve function): My diagnosis - Bilateral Vestibular Hypo Function - Oscillopsia - I'm going back to neurologist because they they think I'm having Vestibular Migraine. No treatment. Vestibular nerves in ears that control my balance are both dead. The study might be testing for an implant and so I may try for that.  The ENT is 99.9 percent sure that I have Vestibular Migraine that I'm having.
Shortness of breath continues; Rash on the Injection Site; Left Arm and Neck Hurt; Feels worst at night (Real Achy); Joint pain; Achy Body; Injection Site hurting again; fatigue; Hurt injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Left Arm and Neck Hurt), CONDITION AGGRAVATED (Feels worst at night (Real Achy)), DYSPNOEA (Shortness of breath continues), VACCINATION SITE RASH (Rash on the Injection Site) and VACCINATION SITE PAIN (Hurt injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE PAIN (Hurt injection site) and FATIGUE (fatigue). On 26-Feb-2021, the patient experienced NECK PAIN (Left Arm and Neck Hurt), CONDITION AGGRAVATED (Feels worst at night (Real Achy)), VACCINATION SITE RASH (Rash on the Injection Site), ARTHRALGIA (Joint pain), MYALGIA (Achy Body) and VACCINATION SITE PAIN (Injection Site hurting again). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath continues). The patient was treated with IBUPROFEN ongoing since an unknown date for Pain, at a dose of 1 dose. On 18-Feb-2021, VACCINATION SITE PAIN (Hurt injection site) and FATIGUE (fatigue) had resolved. At the time of the report, NECK PAIN (Left Arm and Neck Hurt), CONDITION AGGRAVATED (Feels worst at night (Real Achy)), DYSPNOEA (Shortness of breath continues), VACCINATION SITE RASH (Rash on the Injection Site), ARTHRALGIA (Joint pain), MYALGIA (Achy Body) and VACCINATION SITE PAIN (Injection Site hurting again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information or concomitant medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 03-Jul-2021: Follow up received on 03-JUL-2021 and contains no new information
Information has been received from an 18 year old female consumer, for GARDASIL, a Pregnancy Registry product who on 29-JUN-2009 was vaccinated with a first dose of GARDASIL (lot number, route and site not reported). There was no concomitant medication. The patient has been experiencing nausea and abdominal pain after receiving vaccine. The patient reported that since she missed her period in July 2009, she conducted a home urine pregnancy test a couple of days ago and the result came back positive. The patient's last menstrual period was on 08-JUN-2009, the estimated delivery date was 15-MAR-2010. The patient did not seek medical attention. At the time of report, the patient did not recover. Additional information has been requested.
This spontaneous report as received from a consumer via Clinic refers to a currently 66 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 02-NOV-2017, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 1 dose unit (lot # M036728, Expiry date was not reported) for prophylaxis. There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1801USA000166.
Severe, debilitating muscle cramps all over the body beginning 8 hours after vaccine administration and lasting for 30 hours. Also, extreme swelling and tenderness of underarm lymph nodes and at clavicle on the left side of the body, side vaccine was administered to.
Developed hives first on my lower back and right temple later that evening many hives on my left arm hand and left foot late that night developed more hives on my right foot  the next day more hives on my right hand and left right arm still developing new hives but the older ones are getting  better
No adverse event; patient was vaccinated after the expiration date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was vaccinated after the expiration date) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was vaccinated after the expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was vaccinated after the expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient was vaccinated after the expiration date).    At the time of an unannounced visit by a Regulatory Authority representative on 28-Sep-2022, 50 doses of Moderna vaccines were left in the office which were looked well after but they were uncompliant since that lot of Moderna vaccines had expired on 07-Jul-2022.  Additionally it was mentioned that the expiration code on the packaging slip was not the expiration code, instead they had to scan the QR code to determine the actual expiration code, which they failed, by not reading carefully the packing slip.  The patient had received the expired vaccine on 15-Jul-2022.  Concomitant medications details were not reported by the reporter. Treatment details were not reported by the reporter.
Fever, chills, and vomiting for 2 days with redness, swelling of upper right extremity. Diagnosis of cellulitis. Treated with cephalexin.
Patient arrived at local Public Health Clinic for a Pfizer Covid Vaccine Booster (Lot # FK9895) with her husband who also was vaccinated. The injection was given at ~16:45 and patient was sitting in post observation for required 15 minutes. She was offered water at that time but declined. At 17:03 patient reported feeling a slight headache and dizziness and was immediately placed in reclining chair by second nurse.  Alert and oriented. Vital signs were taken at the following 5 minute intervals:   17:05 - Blood Pressure 100/69, Heart Rate 68, Respiratory Rate 16 -reclined in chair 17:10 - Blood Pressure 106/62, Heart Rate 72, Respirator Rate 17 - reclined in chair 17:15 - Blood Pressure 115/72, Heart Rate 62, Respiratory Rate 18- reclined in chair 17:20 - Blood Pressure 137/76, Heart Rate 67, Respiratory Rate 18   Patient reports per her MD that her blood pressure does run on the low side but was unable to give specific range.  Patient reported eating at approximately 15:00 but indicated she had only consumed 2 glasses of water in AM. Patient had no previous history of reaction post previous Pfizer initial vaccine series and reports no underlying health conditions. Patients husband reported his wife had been traveling and had little sleep over the last several days.  Patient was given several glasses of water during vital sign series and said although she felt some improvement she was still experiencing a slight headache and very tired.  Patient was instructed to contact MD if symptoms persist or any new symptoms develop. Patient was escorted with husband to car.
2hr p/vax fever 103.6 & later in evening 103.9;next day 99.9 most of day;no other sx x/dec appetite;fever in spite of APAP q 4-6hr;
pt recv vax 1NOV95 & devel localized cellulitis @ inj site,characterized by erythema & redness;pt was given oral ATB,Pred & Betamethasone;infectious disease specialist reportedly dx the cellulitis;it is unk if pt has recovered as of date
pt recvd vax & exp fine rash on trunk of body & arms; had a little fever (didn't take temp);
This non-serious spontaneous medically confirmed report (initial receipt 01-Sep-2015) concerns a 45-year-old male patient. On 01-Sep-2015, the patient inadvertently received 0.5 mL total of an intramuscular dose of expired AFLURIA (batch number T53909, expiry date: 30-Jun-2015), a medication error. No adverse reaction occurred after the administration. The outcome was reported as recovered. Reporter's outcome: The reporter assessed the event as non-serious, and assessed the event as a medication error. Additional information was received from the reporter on 01-Dec-2015: The reporter assessed the event as unrelated to AFLURIA.
This spontaneous report was received from a registered nurse and refers to a 4 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 25-JUL-2017, the patient was vaccinated with an improperly stored PROQUAD at a dose of 0.5 (units not specified), lot # N013865 with expiry date 31-OCT-2018 (dose number, route and anatomical location not reported) for prophylaxis. Concomitant therapies included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1707USA006208:
Information has been received from a nurse practitioner concerning her 20 year old daughter who in May 2007 and August 2007, was vaccinated with first and second doses of Gardasil vaccine, respectively. Subsequently, on an unspecified date, the patient developed swollen lymph nodes. It was noted that the patient had not yet received her third dose of Gardasil vaccine. At the time of this report, the patient's outcome was unknown. Additional information is not expected.
pt recv vax;rt shoulder to rt elbow was swollen & warm to touch;itching on am;T 99.1;seen by PMD;10x10cm erythema,warmth and mild swelling in rt arm;rx dph & cool compresses;
tinnitus had gone up; hard to sleep.; blurry vision; This is a spontaneous report from a contactable consumer reported for himself. A 67-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (on Friday 8:30 am) as single dose for covid-19 immunisation. The patient medical history included tinnitus for several years. The patient's concomitant medications were not reported. The patient experienced after his first shot, tinnitus had gone up, hard to sleep, Friday night started getting a blurry vision. The patient asked what the efficacy after the first dose was and he was not planning on getting his second dose. He read online after the vaccine tinnitus can get worst. So many people have reported tinnitus post vaccination. Also Friday night he started getting a blurry vision. He closed eyes for 20-30 minutes and it got better. It felt like he was staring at a screen for 10 hours. It was odd. Outcome of the event blurry vision was recovering, of the other events were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Red rash started on right ear and spread down to the right side of neck. Donor complained about itching on face and head as well as neck and back at 6:00 PM. At 6:30 PM she started to complain about itching on both arms. Benadryl was prescribed by center physican and was told to go home and rest.
This spontaneous report as received from a 60 year old female nurse, who was also the patient, refers to a herself. The patient's medical history included a mild headache with other injections. There was no concomitant medication. On approximately 24-APR-2013, "about two weeks ago", the patient was vaccinated with a dose of ZOSTAVAX, subcutaneous for shingles prophylaxis. The nurse noted she "initially developed a mild headache as well swelling and a red bumpy rash at the injection site that was maybe an inch or two in length. The size of the rash grew to about six inches. Cold compresses were given for the patient. No lab diagnostics studies were performed. The reactions subsided about six to seven days ago, on approximately 02-MAY-2013. The outcome of the events was reported as recovered. This is one of several reports from the same reporter (other MARRS # 1305USA004815). Additional information has been requested.
At 9:40 am patient had fasting later drawn and Hep A vaccine given and then following patient started seizuring for 10 seconds.  911 called and patient transported per ambulance 509 to hospital per person mentioned request.
From initial information received on 8/8/03 from the patient regarding an adverse event occurring in the USA, it was reported that the 38 year old female received a TD ADS ADULT vaccination, lot number U0839AA, administered in the right deltoid on 8/2/03 received at an emergency room. Twenty minutes post vaccination the patient had difficulty breathing. Patient now complains of headache, dizziness, malaise, 100 degree F fever, numbness of the arms and legs and difficulty walking. Patient refuses to provide physician information or provide further information. The patient's recovery status was not reported. From additional informaiton received on 14/Aug/2003 through a telephone conversation with the patient's roomate, the patient is being followed by several physicians isnce the adverse event occurred. The complete mailing address of the patient was also provided. No new medically relevant information provided: information got on 14/Aug/2003 not submitted to the Health authorities. 16/Jan/2004: Despite several attempts , no further informaiton was obtainable for this case. No further information is anticipated, this case is considered closed.
Swelling, warm, redness at injection site and 2 inches below which increased in size within 24 hours. Contacted physician and was prescribed Keflex for 10 days. Took all 10 days to completely clear up.